Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h -thieno[2, 3-b][1,5]benzodiazepine and salts thereof

Details for Australian Patent Application No. 2005223338 (hide)

Owner Lek Pharmaceuticals d.d.

Inventors Mesar, Tomaz; Copar, Anton; Ludescher, Johannes; Sturm, Hubert

Agent Griffith Hack

Pub. Number AU-A-2005223338

PCT Pub. Number WO2005/090359

Priority P200400311 16.11.04 SI; P200400079 18.03.04 SI

Filing date 17 March 2005

Wipo publication date 29 September 2005

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090359 Priority application(s): WO2005/090359

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223339-Antithrombotic compound

2005223335-Ether derivatives, their manufacture and use as pharmaceutical agents